Stem Cell Therapy for Myocardial Infarction 2001–2013 Revisited
暂无分享,去创建一个
C. Jung | U. Hoppe | M. Lichtenauer | B. Wernly | C. Schreiber | C. Edlinger | Alexandra Anker | Katja Ruzicka | Catharina Schreiber
[1] J. Vicencio,et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. , 2015, Journal of the American College of Cardiology.
[2] D. Atsma,et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. , 2015, Circulation research.
[3] B. Gersh,et al. Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. , 2014, Journal of molecular and cellular cardiology.
[4] D. Groneberg,et al. MRSA: A Density-Equalizing Mapping Analysis of the Global Research Architecture , 2014, International journal of environmental research and public health.
[5] T. Moccetti,et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. , 2014, Cardiovascular research.
[6] Derek Bell,et al. Using geographical information systems and cartograms as a health service quality improvement tool. , 2014, Spatial and spatio-temporal epidemiology.
[7] Darrel P. Francis,et al. 2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United Nations , 2014, International journal of cardiology.
[8] A. Zeiher,et al. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. , 2014, European heart journal.
[9] E. Marbán,et al. Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy , 2014, Stem cell reports.
[10] D. Groneberg,et al. Influenza: a scientometric and density-equalizing analysis , 2013, BMC Infectious Diseases.
[11] P. Anversa,et al. Stem cells: Bone-marrow-derived cells and heart failure—the debate goes on , 2013, Nature Reviews Cardiology.
[12] P. Doevendans,et al. Stem cells for cardiac repair: an introduction , 2013, Journal of geriatric cardiology : JGC.
[13] R. Vasan,et al. Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. , 2013, Blood.
[14] M. Mildner,et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study , 2011, Basic Research in Cardiology.
[15] A. Zeiher,et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy , 2011, Clinical Research in Cardiology.
[16] M. Mildner,et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction , 2011, Basic Research in Cardiology.
[17] C. Scutaru,et al. Critical analysis of publication prozedures and evaluation regarding ankylosing spondylitis by density-equalizing mapping and scientometeric methods , 2010, Scandinavian journal of rheumatology.
[18] H. Ly,et al. The Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair , 2010, Journal of cardiovascular translational research.
[19] Gerard Pasterkamp,et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. , 2010, Stem cell research.
[20] A. Ganser,et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. , 2009, European heart journal.
[21] S. Mache,et al. Scoliosis: density-equalizing mapping and scientometric analysis , 2009, Scoliosis.
[22] B. Russell,et al. Stem Cell Therapy for Cardiac Repair , 2009, The Journal of cardiovascular nursing.
[23] H. Figulla,et al. Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age , 2009, Clinical Research in Cardiology.
[24] A. Ganser,et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. , 2008, European heart journal.
[25] Michael J Pencina,et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction , 2008, Circulation.
[26] E. Andreu,et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.
[27] X. Ren,et al. Paracrine action of HO‐1‐modified mesenchymal stem cells mediates cardiac protection and functional improvement , 2008, Cell biology international.
[28] C. Scutaru,et al. Journal of Occupational Medicine and Toxicology Models of Asthma: Density-equalizing Mapping and Output Benchmarking , 2022 .
[29] H. Haider,et al. Pharmacologically Preconditioned Skeletal Myoblasts Are Resistant to Oxidative Stress and Promote Angiomyogenesis via Release of Paracrine Factors in the Infarcted Heart , 2007, Circulation research.
[30] A. Zeiher,et al. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. , 2007, European heart journal.
[31] E. Taraldsrud,et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[32] A. Zeiher,et al. Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.
[33] A. Zeiher,et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[34] Joshua M. Hare,et al. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . , 2006, Circulation.
[35] M. Ashraf,et al. Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine Signaling , 2006, Circulation research.
[36] X. Qin,et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. , 2005, The Annals of thoracic surgery.
[37] I. Weissman,et al. Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury , 2005, Circulation.
[38] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[39] W. Hofmann,et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.
[40] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[41] Michael T. Gastner,et al. From The Cover: Diffusion-based method for producing density-equalizing maps. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Zeiher,et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002, Clinical research in cardiology : official journal of the German Cardiac Society.
[43] E. Topol,et al. Autologous cell transplantation for the treatment of damaged myocardium. , 2002, Progress in cardiovascular diseases.
[44] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[45] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[46] Z. Karabekian,et al. Stem Cell Rev and Rep , 2010 .
[47] R. Kloner,et al. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. , 2007, Regenerative medicine.